Intercept Pharmaceuticals Inc Vermögensrendite
Was ist das Vermögensrendite von Intercept Pharmaceuticals Inc?
Vermögensrendite von Intercept Pharmaceuticals Inc ist -12.73%
Was ist die Definition von Vermögensrendite?
Die Vermögensrendite gibt an, wie rentabel die Vermögenswerte eines Unternehmens bei der Erzielung von Einnahmen sind. Sie wird berechnet, indem das Nettoeinkommen durch die durchschnittliche Bilanzsumme geteilt wird.
The return on assets (ROA) tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. It's a useful number for comparing competing companies in the same industry. The number will vary widely across different industries. Return on assets gives an indication of the capital intensity of the company, which will depend on the industry; companies that require large initial investments will generally have lower return on assets. ROAs over 5% are generally considered good.
Vermögensrendite von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Intercept Pharmaceuticals Inc
Was macht Intercept Pharmaceuticals Inc?
we are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive, non-viral liver diseases, including primary biliary cholangitis (pbc), nonalcoholic steatohepatitis (nash), primary sclerosing cholangitis (psc) and biliary atresia. in a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with progressive, non-viral liver disease. we are committed to improving patients’ lives and addressing the liver community’s most pressing needs. our corporate headquarters is located in new york, and we have additional offices in san diego, london and perugia. for more information about intercept, please visit our website at: www.interceptpharma.com and follow us on twitter at: @interceptpharma.
Unternehmen mit vermögensrendite ähnlich Intercept Pharmaceuticals Inc
- Reconstruction Capital II hat Vermögensrendite von -12.78%
- KBL Merger IV hat Vermögensrendite von -12.76%
- Empress Royalty hat Vermögensrendite von -12.75%
- Vermilion hat Vermögensrendite von -12.75%
- Corporacion Empresarial de Materiales de Construccion, S.A hat Vermögensrendite von -12.74%
- The Mint hat Vermögensrendite von -12.74%
- Intercept Pharmaceuticals Inc hat Vermögensrendite von -12.73%
- Saga Plc hat Vermögensrendite von -12.73%
- Rambler Metals and Mining PLC hat Vermögensrendite von -12.72%
- Rambler Metals and Mining PLC hat Vermögensrendite von -12.72%
- Enviva Inc hat Vermögensrendite von -12.72%
- New Relic Inc hat Vermögensrendite von -12.72%
- Gungnir Resources hat Vermögensrendite von -12.72%